Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Given Average Rating of Moderate Buy by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
China Universal Asset Management Co. Ltd. lifted its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 404.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,424 shares of the biotechnology company’s stock after buying an additional 8,356 shares during the […]
The Goldman Sachs Group started coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report published on Tuesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $39.00 price target on the biotechnology company’s stock. RCKT has been the topic of several other reports. UBS Group cut their price objective […]
Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Receives $54 00 Average Price Target from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) Director Gotham Makker sold 274,000 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $28.43, for a total value of $7,789,820.00. Following the transaction, the director now directly owns 365,912 shares of the […]